A recent study has found that inhibition of the trophoblast TLR4/NF-κB/PFKFB3 signaling pathway to correct glycometabolic reprogramming and NLRP3 inflammation-induced pyroptosis may be a treatment approach for preeclampsia [41]. The gene discussed is PFKFB3; the disease is preeclampsia.